Brian Shuch

Brian Shuch

UNVERIFIED PROFILE

Are you Brian Shuch?   Register this Author

Register author
Brian Shuch

Brian Shuch

Publications by authors named "Brian Shuch"

Are you Brian Shuch?   Register this Author

100Publications

2280Reads

19Profile Views

Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription.

Mol Pharmacol 2019 Aug 7;96(2):168-179. Epub 2019 Jun 7.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut (K.Y.C., M.K., F.G., S.C., T.M.P.H., Y.Y.-H.); The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China (M.K.); Ronald Reagan UCLA Medical Center, University of California Los Angeles, Santa Monica, California (D.U., B.M.S.); Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China (H.L.); Department of Biology and Environmental Science, University of New Haven, West Haven, Connecticut (O.M., N.P., C.-H.T.); and Yale Cancer Center, New Haven, Connecticut (Y.Y.-H.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.119.116137DOI Listing
August 2019

Brain Metastasis From Renal-Cell Carcinoma: An Institutional Study.

Clin Genitourin Cancer 2019 Aug 20. Epub 2019 Aug 20.

Department of Urology, Yale School of Medicine, New Haven, CT; Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.08.006DOI Listing
August 2019

Inherited kidney cancer syndromes.

Curr Opin Urol 2019 Jul;29(4):334-343

Institute of Urologic Oncology, UCLA School of Medicine, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000646DOI Listing
July 2019

Glutamine and the Tumor Immune Microenvironment.

Eur Urol 2019 05 30;75(5):764-765. Epub 2019 Jan 30.

UCLA School of Medicine, Los Angeles, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.01.015DOI Listing
May 2019

Active Surveillance Versus Nephron-Sparing Surgery for a Bosniak IIF or III Renal Cyst: A Cost-Effectiveness Analysis.

AJR Am J Roentgenol 2019 Apr 19;212(4):830-838. Epub 2019 Feb 19.

7 Center for Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.20415DOI Listing
April 2019

Outcomes of upper tract urothelial cancer managed non-surgically.

Can J Urol 2019 Apr;26(2):9699-9707

Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
April 2019

Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.

Eur Urol Focus 2019 Apr 27. Epub 2019 Apr 27.

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24054569193012
Publisher Site
http://dx.doi.org/10.1016/j.euf.2019.04.011DOI Listing
April 2019

National trends and economic impact of surgical treatment for benign kidney tumors.

Urol Oncol 2019 03 23;37(3):183.e9-183.e15. Epub 2018 Dec 23.

Yale School of Medicine, Department of Urology, New Haven, CT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.11.019DOI Listing
March 2019

Barriers to pre-treatment genomic characterization of the small renal mass.

Oncotarget 2019 Mar 1;10(18):1667-1668. Epub 2019 Mar 1.

Department of Urology, Institute of Urologic Oncology (IUO), David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422204PMC
March 2019

Determinants of Active Surveillance in Patients With Small Renal Masses.

Urology 2019 Jan 27;123:167-173. Epub 2018 Jul 27.

Yale School of Medicine, Department of Urology, New Haven, CT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2018.07.021DOI Listing
January 2019

Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.

Cancer 2019 Jan 18;125(2):232-238. Epub 2018 Dec 18.

Department of Urology, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31689DOI Listing
January 2019

Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis.

Cancer Epidemiol 2018 10 18;56:31-37. Epub 2018 Jul 18.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151870PMC
October 2018

Genetic Predisposition to Renal Cell Carcinoma: Implications for Counseling, Testing, Screening, and Management.

J Clin Oncol 2018 Oct 29:JCO2018792523. Epub 2018 Oct 29.

Brian Shuch, Yale School of Medicine and Yale Cancer Center, New Haven, CT; and Jin Zhang, RenJi Hospital and Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.2523
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.2523DOI Listing
October 2018

Genetic testing for hereditary prostate cancer: Current status and limitations.

Cancer 2018 08 18;124(15):3105-3117. Epub 2018 Apr 18.

Department of Urology, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31316DOI Listing
August 2018

The Cell Cycle Progression Score: Unclear Role in Renal Cell Carcinoma.

Eur Urol 2018 07 13;74(1):128-129. Epub 2018 Apr 13.

Departments of Urology, Yale School of Medicine, New Haven, Connecticut, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.03.033DOI Listing
July 2018

Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials.

Oncotarget 2018 Apr 27;9(32):22243-22253. Epub 2018 Apr 27.

Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976461PMC
April 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.

BJU Int 2018 01 29;121(1):124-129. Epub 2017 Oct 29.

Department of Urology, Yale School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14042DOI Listing
January 2018

Recommendations for the Management of Rare Kidney Cancers.

Eur Urol 2017 12 16;72(6):974-983. Epub 2017 Jul 16.

Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.040DOI Listing
December 2017

Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.

Cancer 2017 Nov 8;123(22):4363-4371. Epub 2017 Aug 8.

Department of Urology, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30893DOI Listing
November 2017

Current Treatment Landscape of Advanced Papillary Renal Cancer.

J Clin Oncol 2017 09 24;35(26):2981-2983. Epub 2017 Jul 24.

Brian Shuch, Yale School of Medicine, New Haven, CT; Andrew W. Hahn, University of Utah School of Medicine, Salt Lake City, UT; and Neeraj Agarwal, University of Utah School of Medicine and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.3328DOI Listing
September 2017

End-stage renal disease secondary to renal malignancy: Epidemiologic trends and survival outcomes.

Urol Oncol 2017 08 28;35(8):529.e1-529.e7. Epub 2017 Mar 28.

Department of Urology, Yale School of Medicine, New Haven, CT; Department of Radiology, Yale School of Medicine, New Haven, CT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2017.03.003DOI Listing
August 2017

Leukocyte telomere length and renal cell carcinoma survival in two studies.

Br J Cancer 2017 Aug 25;117(5):752-755. Epub 2017 Jul 25.

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr., Rockville, MD 20850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.237DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572185PMC
August 2017

Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies.

Pediatr Blood Cancer 2017 05 2;64(5). Epub 2016 Nov 2.

Department of Urology, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26315DOI Listing
May 2017

Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass.

Urol Clin North Am 2017 May 14;44(2):155-167. Epub 2017 Mar 14.

Department of Radiology, Yale School of Medicine, PO Box 208058, New Haven, CT 06520-8058, USA; Department of Urology, Yale School of Medicine, PO Box 208058, New Haven, CT 06520-8058, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2016.12.002DOI Listing
May 2017

Whole-genome analysis of papillary kidney cancer finds significant noncoding alterations.

PLoS Genet 2017 03 30;13(3):e1006685. Epub 2017 Mar 30.

Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1006685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391127PMC
March 2017

Up-front Targeted Therapy Prior to Cytoreductive Nephrectomy in Treatment-Naive Patients With Metastatic Renal Cell Carcinoma.

JAMA Oncol 2016 Oct;2(10):1273-1274

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2016.1198DOI Listing
October 2016

Management of renal cell carcinoma in young patients and patients with hereditary syndromes.

Curr Opin Urol 2016 09;26(5):396-404

aYale Department of Urology bYale Department of Radiology, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0000000000000322DOI Listing
September 2016

MET Inhibition in Clear Cell Renal Cell Carcinoma.

J Cancer 2016 18;7(10):1205-14. Epub 2016 Jun 18.

1. Department of Urology, Yale School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.14604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934028PMC
July 2016

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma.

Cell Rep 2016 Mar 3;14(10):2476-89. Epub 2016 Mar 3.

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.02.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794376PMC
March 2016

Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.

Proc Natl Acad Sci U S A 2016 Feb 10;113(8):2170-5. Epub 2016 Feb 10.

Department of Pathology, University of California, Los Angeles School of Medicine, Los Angeles, CA 90095;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1525735113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776463PMC
February 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Authors:
W Marston Linehan Paul T Spellman Christopher J Ricketts Chad J Creighton Suzanne S Fei Caleb Davis David A Wheeler Bradley A Murray Laura Schmidt Cathy D Vocke Myron Peto Abu Amar M Al Mamun Eve Shinbrot Anurag Sethi Samira Brooks W Kimryn Rathmell Angela N Brooks Katherine A Hoadley A Gordon Robertson Denise Brooks Reanne Bowlby Sara Sadeghi Hui Shen Daniel J Weisenberger Moiz Bootwalla Stephen B Baylin Peter W Laird Andrew D Cherniack Gordon Saksena Scott Haake Jun Li Han Liang Yiling Lu Gordon B Mills Rehan Akbani Mark D M Leiserson Benjamin J Raphael Pavana Anur Donald Bottaro Laurence Albiges Nandita Barnabas Toni K Choueiri Bogdan Czerniak Andrew K Godwin A Ari Hakimi Thai H Ho James Hsieh Michael Ittmann William Y Kim Bhavani Krishnan Maria J Merino Kenna R Mills Shaw Victor E Reuter Ed Reznik Carl S Shelley Brian Shuch Sabina Signoretti Ramaprasad Srinivasan Pheroze Tamboli George Thomas Satish Tickoo Kenneth Burnett Daniel Crain Johanna Gardner Kevin Lau David Mallery Scott Morris Joseph D Paulauskis Robert J Penny Candace Shelton W Troy Shelton Mark Sherman Eric Thompson Peggy Yena Melissa T Avedon Jay Bowen Julie M Gastier-Foster Mark Gerken Kristen M Leraas Tara M Lichtenberg Nilsa C Ramirez Tracie Santos Lisa Wise Erik Zmuda John A Demchok Ina Felau Carolyn M Hutter Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C Zenklusen Jiashan Zhang Brenda Ayala Julien Baboud Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Adrian Ally Miruna Balasundaram Saianand Balu Rameen Beroukhim Tom Bodenheimer Christian Buhay Yaron S N Butterfield Rebecca Carlsen Scott L Carter Hsu Chao Eric Chuah Amanda Clarke Kyle R Covington Mahmoud Dahdouli Ninad Dewal Noreen Dhalla Harsha V Doddapaneni Jennifer A Drummond Stacey B Gabriel Richard A Gibbs Ranabir Guin Walker Hale Alicia Hawes D Neil Hayes Robert A Holt Alan P Hoyle Stuart R Jefferys Steven J M Jones Corbin D Jones Divya Kalra Christie Kovar Lora Lewis Jie Li Yussanne Ma Marco A Marra Michael Mayo Shaowu Meng Matthew Meyerson Piotr A Mieczkowski Richard A Moore Donna Morton Lisle E Mose Andrew J Mungall Donna Muzny Joel S Parker Charles M Perou Jeffrey Roach Jacqueline E Schein Steven E Schumacher Yan Shi Janae V Simons Payal Sipahimalani Tara Skelly Matthew G Soloway Carrie Sougnez Angela Tam Donghui Tan Nina Thiessen Umadevi Veluvolu Min Wang Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Jane Zhou Jason Bedford Fengju Chen Yao Fu Mark Gerstein David Haussler Katayoon Kasaian Phillip Lai Shiyun Ling Amie Radenbaugh David Van Den Berg John N Weinstein Jingchun Zhu Monique Albert Iakovina Alexopoulou Jeremiah J Andersen J Todd Auman John Bartlett Sheldon Bastacky Julie Bergsten Michael L Blute Lori Boice Roni J Bollag Jeff Boyd Erik Castle Ying-Bei Chen John C Cheville Erin Curley Benjamin Davies April DeVolk Rajiv Dhir Laura Dike John Eckman Jay Engel Jodi Harr Ronald Hrebinko Mei Huang Lori Huelsenbeck-Dill Mary Iacocca Bruce Jacobs Michael Lobis Jodi K Maranchie Scott McMeekin Jerome Myers Joel Nelson Jeremy Parfitt Anil Parwani Nicholas Petrelli Brenda Rabeno Somak Roy Andrew L Salner Joel Slaton Melissa Stanton R Houston Thompson Leigh Thorne Kelinda Tucker Paul M Weinberger Cynthia Winemiller Leigh Anne Zach Rosemary Zuna

Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.

Am J Surg Pathol 2015 Dec;39(12):e1-e18

Departments of *Pathology †Urology, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000562DOI Listing
December 2015

Seminoma in Cryptorchid Testis in Prune Belly Syndrome.

J Urol 2015 Sep 6;194(3):799-800. Epub 2015 Jun 6.

Department of Urology, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.06.015DOI Listing
September 2015

The authors respond.

Epidemiology 2015 Jul;26(4):e49

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, Division of Research, Kaiser Permanente Northern California, Oakland, CA Division of Cancer, Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Department of Urology, Yale School of Medicine, New Haven, CT Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX Division of Cancer, Epidemiology and Genetics, National Cancer Institute, Bethesda, MD Ontario Institute for Cancer Research, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452404PMC
July 2015

Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.

Urol Oncol 2015 Apr 13;33(4):167.e13-20. Epub 2015 Feb 13.

Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2014.11.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417377PMC
April 2015

Kidney cancer, version 3.2015.

J Natl Compr Canc Netw 2015 Feb;13(2):151-9

From Memorial Sloan Kettering Cancer Center; The University of Texas MD Anderson Cancer Center; Huntsman Cancer Institute at the University of Utah; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Alabama at Birmingham Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Mayo Clinic Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Stanford Cancer Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Colorado Cancer Center; City of Hope Comprehensive Cancer Center; Roswell Park Cancer Institute;University of Washington/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0022DOI Listing
February 2015

Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity.

Eur Urol 2015 Jan 21;67(1):85-97. Epub 2014 May 21.

Division of Urologic Oncology, Department of Surgery, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.04.029DOI Listing
January 2015

Chronic kidney disease and risk of renal cell carcinoma: differences by race.

Epidemiology 2015 Jan;26(1):59-67

From the aOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; bDivision of Research, Kaiser Permanente Northern California, Oakland, CA; cDepartment of Urology, Yale School of Medicine, New Haven, CT; dDepartment of Epidemiology, The University of Texas, Houston, TX; and eOntario Institute for Cancer Research, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422505PMC
January 2015

The genetic basis of pheochromocytoma and paraganglioma: implications for management.

Urology 2014 Jun 15;83(6):1225-32. Epub 2014 Mar 15.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572836PMC
June 2014

Clinical management of renal cell carcinoma with venous tumor thrombus.

World J Urol 2014 Jun 22;32(3):581-9. Epub 2014 Apr 22.

Department of Urology, Yale School of Medicine, 310 Cedar Street 238A, New Haven, CT, 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-014-1276-7DOI Listing
June 2014

Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.

J Urol 2013 Dec 11;190(6):1990-8. Epub 2013 Jun 11.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193347PMC
December 2013

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

Eur Urol 2013 Nov 12;64(5):713-719. Epub 2013 Jun 12.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2013.05.059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301057PMC
November 2013

Overall survival advantage with partial nephrectomy: a bias of observational data?

Cancer 2013 Aug 14;119(16):2981-9. Epub 2013 May 14.

Department of Urology, Yale School of Medicine, New Haven, Connecticut; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28141DOI Listing
August 2013

Aerobic glycolysis: a novel target in kidney cancer.

Expert Rev Anticancer Ther 2013 Jun;13(6):711-9

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165485PMC
June 2013

A prospective study of leukocyte telomere length and risk of renal cell carcinoma.

Cancer Epidemiol Biomarkers Prev 2013 May 19;22(5):997-1000. Epub 2013 Mar 19.

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS 8113, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655903PMC
May 2013

Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.

J Urol 2013 Feb 19;189(2):430-5. Epub 2012 Sep 19.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2012.07.139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435969PMC
February 2013

Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Cancer 2013 Jan 12;119(2):388-94. Epub 2012 Nov 12.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27690DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538913PMC
January 2013

The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.

Cancer Causes Control 2013 Jan 21;24(1):167-74. Epub 2012 Nov 21.

Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Bethesda, MD 20892-7240, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-012-0102-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531044PMC
January 2013

Targeting the mTOR pathway in Chromophobe Kidney Cancer.

J Cancer 2012 2;3:152-7. Epub 2012 Apr 2.

1. Urologic Oncology Branch, National Cancer Institute, 10 Center Drive, CRC, Building 10, Room 1-5940, Bethesda, MD 20892, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.4378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319981PMC
October 2012

Kidney cancer: Is incomplete renal ablation linked to tumour progression?

Nat Rev Urol 2012 Oct 28;9(10):547-8. Epub 2012 Aug 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2012.174DOI Listing
October 2012

Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Oncologist 2012 10;17(1):46-54. Epub 2012 Jan 10.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive MSC 1107, Building 10, CRC, Room 1-5940, Bethesda, Maryland 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267822PMC
June 2012

Prospective study comparing two techniques of renal clamping in laparoscopic partial nephrectomy: impact on perioperative parameters.

J Endourol 2012 May 8;26(5):509-14. Epub 2011 Aug 8.

Department of Surgery, Division of Urology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/end.2011.0088DOI Listing
May 2012

The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors.

Urol Clin North Am 2012 May 23;39(2):133-48, v. Epub 2012 Feb 23.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, CRC, Room 1-5940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2012.01.006DOI Listing
May 2012

The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.

J Urol 2011 Dec 19;186(6):2168-74. Epub 2011 Oct 19.

Institute of Urologic Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2011.07.068DOI Listing
December 2011

Surgical management of large renal tumors.

Expert Rev Anticancer Ther 2011 Dec;11(12):1889-900

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892-1107, USA.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/6e61e8b3d6e461a0cc0f3299
Web Search
http://informahealthcare.com/doi/abs/10.1586/era.11.129
Publisher Site
http://dx.doi.org/10.1586/era.11.129DOI Listing
December 2011

Repeat partial nephrectomy: surgical, functional and oncological outcomes.

Curr Opin Urol 2011 Sep;21(5):368-75

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOU.0b013e32834964eaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173810PMC
September 2011

Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance.

BJU Int 2011 Aug 19;108(3):343-8. Epub 2010 Nov 19.

Institute of Urologic Oncology, UCLA Department of Urology, Los Angeles, CA 90095-1738, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1464-410X.2010.09871.x
Publisher Site
http://dx.doi.org/10.1111/j.1464-410X.2010.09871.xDOI Listing
August 2011

Editorial comment.

J Urol 2011 May 21;185(5):1589-90; author reply 1590. Epub 2011 Mar 21.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.12.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731868PMC
May 2011

Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time.

Can Urol Assoc J 2011 Apr;5(2):89-95

Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC; Institute of Urologic Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA Dr. Pouliot was supported in part by a scholarship from Les Bourses McLaughlin du Doyen, a scholarship from the Association des Urologues du Québec and a scholarship from the CMDP (Committee of physicians, dentists and pharmacists) of the Laval University Hospital Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.10044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104439PMC
April 2011

Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?

BJU Int 2011 Mar;107(5):724-728

Departments of Urology and Biostatistics, University of CaliforniaDepartment of Urology, University of Southern Califormia, Los Angeles, CAMayo Clinic Department of Urology, Rochester, MN, USADepartment of Urology, RennesDepartment of Urology, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09488.xDOI Listing
March 2011

Immunological therapy in urological malignancy: novel combination strategies.

Int J Urol 2011 Feb 12;18(2):94-101. Epub 2010 Nov 12.

Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1442-2042.2010.02664.xDOI Listing
February 2011

Ultrasound-based combination therapy: potential in urologic cancer.

Expert Rev Anticancer Ther 2011 Jan;11(1):107-13

Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.10.174DOI Listing
January 2011

Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.

Cancer 2010 Oct;116(20):4696-702

Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California 90025, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25279DOI Listing
October 2010

Contemporary management of renal tumors with venous tumor thrombus.

J Urol 2010 Sep;184(3):833-41; quiz 1235

Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.04.071DOI Listing
September 2010